Target intelligence / Profile preview

Small cysteine and glycine repeat-containing protein 3 (SCYGR3)

Target
SCYGR3
Molecular classification
Other (Keratin-associated protein family)
01

Overview

Small cysteine and glycine repeat-containing protein 3 (SCYGR3) is a member of the keratin-associated protein (KAP) family, which forms the matrix that cross-links with keratin intermediate filaments to provide structural integrity and mechanical properties to keratinized tissues such as hair, nails, and wool. KAPs, including SCYGR3, are not signal transduction molecules, receptors, enzymes, or transcription factors, but rather structural components with diverse and often family-member-specific functions. Expression and proper regulation of these proteins are essential for the normal development and maintenance of hair and related integumentary structures, affecting characteristics like fiber strength, resilience, and quality[2]. There is currently no evidence to support SCYGR3 as a therapeutic target or receptor, and it does not have a defined role in major human diseases.\n\nNo information was found linking SCYGR3 (KRTAP28-3) to classical drug targeting, biomarker use, or safety concerns. If you seek a typical receptor, enzyme, or transporter, this is not an appropriate target; it is best classified under structural/other protein categories within molecular family ontologies.

Other names
Small cysteine and glycine repeat containing 3SCYGR3Keratin-associated protein 28-3KRTAP28-3keratin associated protein 28-3
02

Biological functions

Structural support in keratinized tissues such as hair, nails, and woolinteraction with keratin intermediate filamentscontribution to the physical and mechanical properties of these structures[2]
03

Disease associations

Other (No direct evidence of involvement in diseases such as cancer, inflammation, neurodegeneration, etc.; may indirectly affect disease if keratinization is disrupted, but not a primary disease driver)

Beyond the preview

Go deeper on Small cysteine and glycine repeat-containing protein 3 (SCYGR3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small cysteine and glycine repeat-containing protein 3 (SCYGR3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call